ES2607144T3 - Composiciones y métodos para incrementar la absorción de hierro - Google Patents
Composiciones y métodos para incrementar la absorción de hierro Download PDFInfo
- Publication number
- ES2607144T3 ES2607144T3 ES08861633.9T ES08861633T ES2607144T3 ES 2607144 T3 ES2607144 T3 ES 2607144T3 ES 08861633 T ES08861633 T ES 08861633T ES 2607144 T3 ES2607144 T3 ES 2607144T3
- Authority
- ES
- Spain
- Prior art keywords
- iron
- composition
- peptides
- animal
- absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 239
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 118
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title description 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 61
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 61
- 241001465754 Metazoa Species 0.000 claims abstract description 38
- 241000282414 Homo sapiens Species 0.000 claims abstract description 26
- 230000037406 food intake Effects 0.000 claims abstract description 17
- 241000972773 Aulopiformes Species 0.000 claims abstract description 8
- 235000019515 salmon Nutrition 0.000 claims abstract description 8
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 claims description 13
- 235000013373 food additive Nutrition 0.000 claims description 9
- 239000002778 food additive Substances 0.000 claims description 9
- 235000015872 dietary supplement Nutrition 0.000 claims description 8
- 235000005911 diet Nutrition 0.000 claims description 7
- 230000037213 diet Effects 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 235000021323 fish oil Nutrition 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 102000004338 Transferrin Human genes 0.000 description 20
- 108090000901 Transferrin Proteins 0.000 description 20
- 239000012581 transferrin Substances 0.000 description 19
- 102000008857 Ferritin Human genes 0.000 description 17
- 108050000784 Ferritin Proteins 0.000 description 17
- 238000008416 Ferritin Methods 0.000 description 17
- 241000282472 Canis lupus familiaris Species 0.000 description 16
- 230000029087 digestion Effects 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 235000019688 fish Nutrition 0.000 description 12
- 241000251468 Actinopterygii Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 208000007502 anemia Diseases 0.000 description 9
- 241000282412 Homo Species 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 230000007071 enzymatic hydrolysis Effects 0.000 description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 102000011632 Caseins Human genes 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 235000013330 chicken meat Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000005018 casein Substances 0.000 description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 5
- 235000021240 caseins Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229940119224 salmon oil Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XMGJGSKRRWXOIF-UHFFFAOYSA-N 2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1CCCCC1C(C1=CSC=C1)C(=O)OCCN1CCCCCC1 XMGJGSKRRWXOIF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 241000607626 Vibrio cholerae Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 150000003278 haem Chemical class 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 229940118696 vibrio cholerae Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- 108010028690 Fish Proteins Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 208000022440 X-linked sideroblastic anemia 1 Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000020940 control diet Nutrition 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037765 diseases and disorders Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229960001781 ferrous sulfate Drugs 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- -1 for example Chemical compound 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000007475 hemolytic anemia Diseases 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108010009355 microbial metalloproteinases Proteins 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001175 peptic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000007065 protein hydrolysis Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- XXDVUVPHJGZWQC-QHTZZOMLSA-L (2s)-2-amino-5-hydroxy-5-oxopentanoate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O XXDVUVPHJGZWQC-QHTZZOMLSA-L 0.000 description 1
- GDTWSDAEFQZUPS-UHFFFAOYSA-N 4-[[(3-aminonaphthalen-2-yl)amino]methyl]benzoic acid Chemical compound NC1=CC2=CC=CC=C2C=C1NCC1=CC=C(C(O)=O)C=C1 GDTWSDAEFQZUPS-UHFFFAOYSA-N 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 206010002080 Anaemia vitamin B12 deficiency Diseases 0.000 description 1
- 206010002965 Aplasia pure red cell Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 101000766307 Gallus gallus Ovotransferrin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 206010019902 Hereditary sideroblastic anaemia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010027527 Microangiopathic haemolytic anaemia Diseases 0.000 description 1
- 208000036696 Microcytic anaemia Diseases 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000277263 Salmo Species 0.000 description 1
- 241000277289 Salmo salar Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000013685 acquired idiopathic sideroblastic anemia Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 230000037037 animal physiology Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- MSNWSDPPULHLDL-UHFFFAOYSA-K ferric hydroxide Chemical compound [OH-].[OH-].[OH-].[Fe+3] MSNWSDPPULHLDL-UHFFFAOYSA-K 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 229960001604 ferrous succinate Drugs 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 108010007119 flavourzyme Proteins 0.000 description 1
- 201000008909 folic acid deficiency anemia Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- UBUHAZKODAUXCP-UHFFFAOYSA-N iron(2+);oxygen(2-);hydrate Chemical class O.[O-2].[Fe+2] UBUHAZKODAUXCP-UHFFFAOYSA-N 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1387307P | 2007-12-14 | 2007-12-14 | |
| US13873P | 2007-12-14 | ||
| PCT/US2008/086668 WO2009079401A2 (en) | 2007-12-14 | 2008-12-12 | Compositions and methods for increasing iron absorption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2607144T3 true ES2607144T3 (es) | 2017-03-29 |
Family
ID=40796108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08861633.9T Active ES2607144T3 (es) | 2007-12-14 | 2008-12-12 | Composiciones y métodos para incrementar la absorción de hierro |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2231171B1 (enExample) |
| JP (1) | JP5554719B2 (enExample) |
| KR (1) | KR101669291B1 (enExample) |
| CA (1) | CA2709159C (enExample) |
| DK (1) | DK2231171T3 (enExample) |
| ES (1) | ES2607144T3 (enExample) |
| HR (1) | HRP20161618T1 (enExample) |
| HU (1) | HUE029966T2 (enExample) |
| LT (1) | LT2231171T (enExample) |
| PL (1) | PL2231171T3 (enExample) |
| PT (1) | PT2231171T (enExample) |
| SI (1) | SI2231171T1 (enExample) |
| WO (1) | WO2009079401A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6646309B2 (ja) * | 2015-03-25 | 2020-02-14 | テルモ株式会社 | ヘプシジン−２５産生抑制剤 |
| CN107814832B (zh) * | 2017-10-19 | 2020-10-16 | 中国计量大学 | 一种马鲛鱼蛋白来源的铁螯合肽及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04158761A (ja) * | 1990-10-19 | 1992-06-01 | Nippon Kayaku Co Ltd | ペプタイド含有鉄分強化食品 |
| US5662922A (en) * | 1992-01-20 | 1997-09-02 | Christensen; Borge Holm | Iron-containing composition for the prevention of anaemia and a method for producing the composition |
| JP3167402B2 (ja) * | 1992-02-25 | 2001-05-21 | 仙味エキス株式会社 | 鉄吸収促進組成物 |
| JP2683529B2 (ja) * | 1994-02-08 | 1997-12-03 | 静次 片野 | ゲル状食品 |
| WO2003055901A1 (en) * | 2001-12-25 | 2003-07-10 | Senmi Ekisu Co., Ltd. | Novel peptide sy |
| DK175501B1 (da) | 2002-12-02 | 2004-11-15 | Green Earth | Anlæg og fremgangsmåde til kontinuerlig hydrolyse af et proteinholdigt animalsk eller vegetabilsk råmateriale |
| JP4715078B2 (ja) * | 2003-04-16 | 2011-07-06 | 大正製薬株式会社 | 鉄化合物配合内服用液体組成物 |
| CN1270638C (zh) * | 2004-03-13 | 2006-08-23 | 中国水产科学研究院黄海水产研究所 | 功能食品的基料液及其制备方法 |
| US7495076B2 (en) * | 2005-10-13 | 2009-02-24 | Gu Jennifer L | Mineral collagen chelates and methods of making and using same |
| JP5229959B2 (ja) | 2009-02-24 | 2013-07-03 | 富士フイルム株式会社 | 投写レンズおよびこれを用いた投写型表示装置 |
-
2008
- 2008-12-12 LT LTEP08861633.9T patent/LT2231171T/lt unknown
- 2008-12-12 SI SI200831723A patent/SI2231171T1/sl unknown
- 2008-12-12 DK DK08861633.9T patent/DK2231171T3/en active
- 2008-12-12 EP EP08861633.9A patent/EP2231171B1/en active Active
- 2008-12-12 CA CA2709159A patent/CA2709159C/en active Active
- 2008-12-12 KR KR1020107015618A patent/KR101669291B1/ko active Active
- 2008-12-12 HU HUE08861633A patent/HUE029966T2/en unknown
- 2008-12-12 JP JP2010538203A patent/JP5554719B2/ja active Active
- 2008-12-12 PL PL08861633T patent/PL2231171T3/pl unknown
- 2008-12-12 ES ES08861633.9T patent/ES2607144T3/es active Active
- 2008-12-12 HR HRP20161618TT patent/HRP20161618T1/hr unknown
- 2008-12-12 WO PCT/US2008/086668 patent/WO2009079401A2/en not_active Ceased
- 2008-12-12 PT PT88616339T patent/PT2231171T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2231171T1 (sl) | 2017-03-31 |
| WO2009079401A3 (en) | 2009-10-01 |
| KR101669291B1 (ko) | 2016-10-25 |
| PT2231171T (pt) | 2016-12-21 |
| EP2231171B1 (en) | 2016-10-05 |
| CA2709159C (en) | 2017-04-11 |
| HUE029966T2 (en) | 2017-04-28 |
| DK2231171T3 (en) | 2017-01-09 |
| EP2231171A4 (en) | 2011-04-06 |
| CA2709159A1 (en) | 2009-06-25 |
| JP5554719B2 (ja) | 2014-07-23 |
| EP2231171A2 (en) | 2010-09-29 |
| JP2011506479A (ja) | 2011-03-03 |
| LT2231171T (lt) | 2017-01-25 |
| WO2009079401A2 (en) | 2009-06-25 |
| HRP20161618T1 (hr) | 2017-01-13 |
| KR20100112133A (ko) | 2010-10-18 |
| PL2231171T3 (pl) | 2017-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6028399A (en) | Canine milk substitute | |
| US9597308B2 (en) | N-acetyl L-cysteine chelates and methods for making and using the same | |
| Mwangi et al. | Absorption of iron from edible house crickets: a randomized crossover stable-isotope study in humans | |
| BR112020015369A2 (pt) | Hidrolisado de proteína marinho com baixo teor de fluoreto e trimetilamina | |
| El-Shenawy et al. | Effect of Iron Nanoparticles on the Development of Fish Farm Feeds. | |
| US20150196048A1 (en) | Bovine meat compositions having enhanced quality, nutritive and health values obtained from enrichment diets | |
| ES2607144T3 (es) | Composiciones y métodos para incrementar la absorción de hierro | |
| JP2012152220A (ja) | 猫における甲状腺機能亢進症を予防する方法並びに限定されたセレン及びヨウ素を含む組成物 | |
| Miao et al. | Effect on amino acid and mineral content of the loach (Misgurnus anguillicaudatus) by adding Fe (II) chelating hairtail protein hydrolysates (Fe (II)‐HPH) to the feed | |
| Tahergorabi et al. | Seafood proteins and human health | |
| Sharma et al. | Food products of non–plant origin to combat the problem of nutritional deficiency | |
| Tuhy et al. | Trace elements in animal nutrition | |
| Villarroel et al. | Effect of dietary protein on heme iron uptake by Caco-2 cells | |
| Cayot et al. | Iron fortification of milk and dairy products | |
| Wahid et al. | The impact of glycine and glutamate, as components of glutathione precursors, on the productivity, digestive performance and blood profile of weaning pigs | |
| Joe et al. | Nutritional value of Pacific herring bone co-ingested with fish meat as a calcium source in retort seafood | |
| CA2922396C (en) | N-acetyl l-cysteine chelates and methods for making and using the same | |
| Jia et al. | Selenium supplementation effect of selenium-chelating peptide from sturgeon (Acipenseridae) heads and prevention of liver injury in selenium-deficient mice | |
| Lönnerdal | Trace elements in infancy: a supply/demand perspective | |
| Dold | Membrane filtration processing of infant milk formula alters protein digestion in young pigs | |
| Malik et al. | Dietary Proteins and Health | |
| Al Mamun et al. | Nutritional Potential and Health Risks of Achatina fulica Land Snail: An Unutilized Food Source | |
| Pepito et al. | Nutritional quality of the egg mass locally known as “lukot’of the wedge seahare dolabella auricularia (Lightfoot, 1786) | |
| SANNAMANI | Development of Iron and Zinc Enriched Eggs and Meat of Japanese Quails as Functional Food | |
| Etcheverry | Studies in human milk and mineral bioavailability using Caco-2 cells |